Mona Abdi,Elbay Aliyev,Brett Trost,Muhammad Kohailan,Waleed Aamer,Najeeb Syed,Rulan Shaath,Geethanjali Devadoss Gandhi,Worrawat Engchuan,Jennifer Howe,Bhooma Thiruvahindrapuram,Melissa Geng,Joe Whitney,Amira Syed,Jyothi Lakshmi,Sura Hussein,Najwa Albashir,Amal Hussein,Ilaria Poggiolini,Saba F Elhag,Sasirekha Palaniswamy,Marios Kambouris,Maria de Fatima Janjua,Mohamed O El Tahir,Ahsan Nazeer,Durre Shahwar,Muhammad Waqar Azeem,Younes Mokrab,Nazim Abdel Aati,Ammira Akil,Stephen W Scherer,Madeeha Kamal,Khalid A Fakhro

Abstract:Background: Autism spectrum disorder (ASD) is a neurodevelopmental condition characterized by impaired social and communication skills, restricted interests, and repetitive behaviors. The prevalence of ASD among children in Qatar was recently estimated to be 1.1%, though the genetic architecture underlying ASD both in Qatar and the greater Middle East has been largely unexplored. Here, we describe the first genomic data release from the BARAKA-Qatar Study-a nationwide program building a broadly consented biorepository of individuals with ASD and their families available for sample and data sharing and multi-omics research. Methods: In this first release, we present a comprehensive analysis of whole-genome sequencing (WGS) data of the first 100 families (372 individuals), investigating the genetic architecture, including single-nucleotide variants (SNVs), copy number variants (CNVs), tandem repeat expansions (TREs), as well as mitochondrial DNA variants (mtDNA) segregating with ASD in local families. Results: Overall, we identify potentially pathogenic variants in known genes or regions in 27 out of 100 families (27%), of which 11 variants (40.7%) were classified as pathogenic or likely-pathogenic based on American College of Medical Genetics (ACMG) guidelines. Dominant variants, including de novo and inherited, contributed to 15 (55.6%) of these families, consisting of SNVs/indels (66.7%), CNVs (13.3%), TREs (13.3%), and mtDNA variants (6.7%). Moreover, homozygous variants were found in 7 families (25.9%), with a sixfold increase in homozygous burden in consanguineous versus non-consanguineous families (13.6% and 1.8%, respectively). Furthermore, 28 novel ASD candidate genes were identified in 20 families, 23 of which had recurrent hits in MSSNG and SSC cohorts. Conclusions: This study illustrates the value of ASD studies in under-represented populations and the importance of WGS as a comprehensive tool for establishing a molecular diagnosis for families with ASD. Moreover, it uncovers a significant role for recessive variation in ASD architecture in consanguineous settings and provides a unique resource of Middle Eastern genomes for future research to the global ASD community.

Genome Sequencing Identifies 13 Novel Candidate Risk Genes for Autism Spectrum Disorder in a Qatari Cohort

The genetic landscape of autism spectrum disorder in the Middle Eastern population

Genomic architecture of autism spectrum disorder in Qatar: The BARAKA-Qatar Study

Detection of Clinically Relevant Genetic Variants in Autism Spectrum Disorder by Whole-Genome Sequencing

Autism spectrum disorder trios from consanguineous populations are enriched for rare biallelic variants, identifying 32 new candidate genes

Integration of Transcriptome and Exome Genotyping Identifies Significant Variants with Autism Spectrum Disorder

Whole genome sequencing resource identifies 18 new candidate genes for autism spectrum disorder

Genome-wide Analyses of Exonic Copy Number Variants in a Family-Based Study Point to Novel Autism Susceptibility Genes.

Analysis of recent shared ancestry in a familial cohort identifies coding and noncoding autism spectrum disorder variants

The Genetics of Autism Spectrum Disorder in an East African Familial Cohort

Discovery and Validation of Novel Genes in a Large Chinese Autism Spectrum Disorder Cohort.

Biallelic variants identified in 36 Pakistani families and trios with autism spectrum disorder

Common risk variants identified in autism spectrum disorder

eQTL colocalization analysis highlights novel susceptibility genes in Autism Spectrum Disorders (ASD)

Discovery of a novel cytokine signature for the diagnosis of autism spectrum disorder in young Arab children in Qatar

Discovery and validation of novel genes in a large Chinese ASD cohort

Whole-genome sequencing identifies novel genes for autism in Chinese trios

Targeted Resequencing of 358 Candidate Genes for Autism Spectrum Disorder in a Chinese Cohort Reveals Diagnostic Potential and Genotype-Phenotype Correlations

De Novo Variants in Chinese ASD Trios Reveal Distinct Genetic Basis Underlying Autism with and Without Developmental Delay

Autism genome-wide copy number variation reveals ubiquitin and neuronal genes

Identification of De Novo Mutations in the Chinese Autism Spectrum Disorder Cohort Via Whole-Exome Sequencing Unveils Brain Regions Implicated in Autism